Viracta Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viracta Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $96k | 169k | 0.57 |
| 2023-09-30 | $68 | 65 | 1.05 |
| 2022-12-31 | $4.7k | 3.3k | 1.44 |
| 2022-09-30 | $0 | 2.5k | 0.00 |
| 2022-06-30 | $0 | 9 | 0.00 |
| 2022-03-31 | $0 | 9 | 0.00 |
| 2021-12-31 | $0 | 9 | 0.00 |
| 2021-09-30 | $0 | 871 | 0.00 |
| 2021-06-30 | $0 | 9 | 0.00 |
| 2021-03-31 | $0 | 11 | 0.00 |